Research

Our sector specialties include: Consumer; Healthcare; Power & Energy Transition; and Technology/Media. Guggenheim Equity Research analysts average 18 years of Wall Street and industry experience, bringing our clients rich perspectives and deep domain expertise.

Rigorous primary research is central to our approach. Innovation and disruption are constants in the sectors we cover and on-the-ground work keeps our team at the leading edge of trend changes for the benefit of our clients. Our signature research products uncover these findings and include:

The Guggenheim 360° series spotlights our analysts' most differentiated work—research that reflects a deep understanding of our covered industries, primary studies using proprietary methods, access to subject matter experts, thought-provoking conclusions, and actionable portfolio ideas;
The Guggenheim Data Insights series harnesses alternative data sources to identify changes in fundamental trends in the industries and businesses we cover. With an emphasis on complex and unstructured data sets, our data science team delivers fundamental observations for our analysts to incorporate into their investment opinions.

Meet the Teams

Consumer

The Consumer team covers hardline and softline retail, automotive, restaurants, and e-commerce.

View the Team

Power & Energy Transition

The Power & Energy Transition team covers energy & industrial technology, power, and utilities.

View the Team

Healthcare

The Healthcare team covers biotechnology, biopharmaceuticals, healthcare IT, and healthcare services.

View the Team

Technology & Media

The Technology & Media team covers software, media, and entertainment.

View the Team

For access to our research offerings and products, please contact your Guggenheim Securities Sales representative or email GSInfo@guggenheimpartners.com.

Already Registered? View the content library on the research portal (login required).

360° and Data Insights

Retailing/Department Stores & Specialty Softlines

A Discussion With Three Leaders in Sustainability

Biotechnology

On RNA Editing–Putting ADAR on Your RADAR

Biotechnology

Summer May Be Ending, but Things Are Heating Up for Innate Immunity Drug Development: Featuring Top 10 Hot Targets in Neuro/Immunology

I&I Spotlight Series – Treg-based Therapies

Senior Managing Directors Whitney Wolfe and Yatin Suneja partake in a Q&A session regarding the future of the Treg-Therapies.

Watch Video

Tech-Enabled Care Industry Overview

Head of Equity Research Craig Peckham, Healthcare IT & Services Research Analysts Sandy Draper and Jack Wallace discuss their insights on the tech-enabled care industry.

Watch Video

Highlights From the Second Guggenheim Targeted Protein Day

Senior Managing Director Michael Schmidt discusses the key topics from the event.

Watch Video

Conferences

Date	Sector	Conference Name
6/20-6/23	Healthcare	Biopharma's Next Decade Bus Tour: Views from the Top on Global Strategy and Innovation
6/22	Healthcare	Biopharma's Next Decade Bus Tour Reception